|
"jiaang wt"的相關文件
顯示項目 11-35 / 86 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-11-30 |
Aminothiazole compounds as protein kinase inhibitors
|
Shih, C;Jiaang, WT;Tsai, HJ |
| 國家衛生研究院 |
2021-10-07 |
Aminothiazole compounds as protein kinase inhibitors
|
Shih, C;Jiaang, WT;Tsai, HJ |
| 國家衛生研究院 |
2021-08-12 |
Xanthine derivatives reveal an allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2)
|
Lee, LC;Peng, YH;Chang, HH;Hsu, T;Lu, CT;Huang, CH;Hsueh, CC;Kung, FC;Kuo, CC;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2021-08-01 |
DBPR108, a novel dipeptidyl peptidase-4 inhibitor with antihyperglycemic activity
|
Yeh, KC;Yeh, TK;Huang, CY;Hu, CB;Wang, MH;Huang, YW;Chou, LH;Ho, HH;Song, JS;Hsu, T;Jiaang, WT;Chao, YS;Chen, CT |
| 國家衛生研究院 |
2020-12-23 |
Aminothiazole compounds as protein kinase inhibitors
|
Shih, C;Jiaang, WT;Tsai, HJ |
| 國家衛生研究院 |
2020-10-16 |
Potent and orally active purine-based fetal hemoglobin inducers for treating Beta-thalassemia and sickle cell disease
|
Lai, ZS;Yeh, TK;Chou, YC;Hsu, T;Lu, CT;Kung, FC;Hsieh, MY;Lin, CH;Chen, CT;James Shen, CK;Jiaang, WT |
| 國家衛生研究院 |
2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia
|
Lin, WH;Wu, SY;Yeh, TK;Chen, CT;Song, JS;Shiao, HY;Kuo, CC;Hsu, T;Lu, CT;Wang, PC;Wu, TS;Peng, YH;Lin, HY;Chen, CP;Weng, YL;Kung, FC;Wu, MH;Su, YC;Huang, KW;Chou, LH;Hsueh, CC;Yen, KJ;Kuo, PC;Huang, CL;Chen, LT;Shih, C;Tsai, HJ;Jiaang, WT |
| 國家衛生研究院 |
2019-11-12 |
Composto
|
Tsai, TY;Hsu, T;Jiaang, WT;Chao, YS |
| 國家衛生研究院 |
2019-07 |
Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216
|
Kuo, CC;Jiaang, WT;Ou, JJ;Chen, CT;Hsu, SC;Shih, C;Lin, LM;Sun, M;Wang, YH;Huang, ZT;Chang, JY;Ueng, SH |
| 國家衛生研究院 |
2019-05-28 |
Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform
|
Lin, HS;Huang, YL;Wang, YS;Hsiao, E;Hsu, TA;Shiao, HY;Jiaang, WT;Sampurna, BP;Lin, KH;Wu, MS;Lai, GM;Yuh, CH |
| 國家衛生研究院 |
2019-05-28 |
Aminothiazole compounds as protein kinase inhibitors
|
Jiaang, WT;Shih, C;Tsai, HJ |
| 國家衛生研究院 |
2019-04-10 |
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants
|
Wu, TS;Lin, WH;Tsai, HJ;Hsueh, CC;Hsu, T;Wang, PC;Lin, HY;Peng, YH;Lu, CT;Lee, LC;Tu, CH;Kung, FC;Shiao, HY;Yeh, TK;Song, JS;Chang, JY;Su, YC;Chen, LT;Chen, CT;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2018-08-24 |
BPR1J373, a novel multi-targeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
|
Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TJ;Wu, CC;Lin, HY;Chen, LT |
| 國家衛生研究院 |
2018-08-24 |
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
|
Tsai, HJ;Jiaang, WT;Shih, NY;Fletcher, JA;Lin, MJ;Yang, MY;Chen, CT;Hsu, TAJ;Wu, CC;Lin, HY;Chen, LT |
| 國家衛生研究院 |
2018-08-14 |
Aminothiazole compounds
|
Jiaang, WT;Hsu, T |
| 國家衛生研究院 |
2017-03-21 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-12 |
Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST
|
Shiao, HY;Tsai, HJ;Lin, WH;Tsu, TA;Yeh, TK;Chen, CT;Jiaang, WT |
| 國家衛生研究院 |
2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia
|
Chen, LT;Chen, CT;Jiaang, WT;Chen, TY;Butterfield, JH;Shih, NY;Hsu, JT;Lin, HY;Lin, SF;Tsai, HJ |
| 國家衛生研究院 |
2016-08-30 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-04-12 |
Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK)
|
Tu, CH;Lin, WH;Peng, YH;Hsu, T;Wu, JS;Chang, CY;Lu, CT;Lyu, PC;Shih, C;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2016-02-09 |
Pyrazole compounds and thiazole compounds as protein kinases inhibitors
|
Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS |
| 國家衛生研究院 |
2015-11-13 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations
|
Chen, CT;Hsu, JTA;Lin, WH;Lu, CT;Yen, SC;Hsu, T;Huang, YL;Song, JS;Chen, CH;Chou, LH;Yen, KJ;Chen, CP;Kuo, PC;Huang, CL;Eugene Liu, H;Chao, YS;Yeh, TK;Jiaang, WT |
| 國家衛生研究院 |
2014-08-01 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-05-12 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
顯示項目 11-35 / 86 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
